Definitive Contract 36C25621C0020
- Not listed
- Veracyte, Inc. was awarded a $451.2K firm fixed-price purchase order by Veterans Integrated Service Network 17 (VISN 17), a civilian component of the Department of Veterans Affairs, for genomic laboratory testing services. The contract was awarded on August 15, 2022, with an ultimate completion date of August 14, 2027, and will be performed in Dallas, Texas. This award carries no small business set-aside designation and represents a continuation of Veracyte's established relationship with the...
- The Department of Veterans Affairs, Veterans Integrated Service Network 8 (VISN 8), awarded a delivery order valued at $96,960 to Veracyte, Inc. for gene testing services. The award, issued on February 5, 2026, is a firm fixed-price delivery order with an ultimate completion date of February 4, 2027, and carries no small business set-aside designation. The contract will be performed in South San Francisco, California, where Veracyte maintains its headquarters. This delivery order is issued under...
- The Department of Veterans Affairs, Veterans Integrated Service Network 16 (VISN 16), awarded a $12,928 delivery order to Veracyte, Inc. for thyroid testing services. This fixed-price contract with economic price adjustment authority has a completion date of September 30, 2026, and will be performed in Fayetteville, Arkansas. The award represents a non-set-aside delivery order issued without preferential contracting designations, reflecting the specialized and proprietary nature of Veracyte's...
- The Department of Veterans Affairs, Veterans Integrated Service Network 23 (VISN 23), awarded a delivery order to Veracyte, Inc. for reference laboratory services under an Indefinite Delivery/Indefinite Quantity (IDIQ) contract. The award, issued on May 1, 2024, carries a ceiling value of $11.2K and an ultimate completion date of April 30, 2025. Veracyte, Inc., a South San Francisco-based medical diagnostic company specializing in advanced genomic testing, will deliver molecular and genomic...
- The Department of Veterans Affairs, Veterans Integrated Service Network 23 (VISN 23), awarded a delivery order valued at $168,000 to Veracyte, Inc. for reference laboratory services with a completion date of April 30, 2026. This task order was issued under an existing Indefinite Delivery/Indefinite Quantity (IDIQ) contract for Veracyte Reference Laboratory Services with VISN 23, which carries a total ceiling value of $2 million through April 2028. The contract utilizes firm fixed pricing and was...
- This is a firm fixed-price delivery order awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 16 to Veracyte, Inc., a for-profit medical diagnostic company. The $165,200.00 contract is for the delivery of AFIRMA testing services to the Fayetteville VA Medical Center from April 1, 2026 through April 30, 2027, with a potential completion date of April 30, 2029. Veracyte will provide specialized genomic testing services to support precision medicine and informed...
- Veracyte, Inc. received a delivery order valued at $42,000 from Veterans Integrated Service Network (VISN) 23 for reference laboratory services, with an ultimate completion date of April 30, 2026. This firm fixed-price delivery order, awarded on May 1, 2025, carries no small business set-aside designation and represents work to be performed at Veracyte's headquarters facility in South San Francisco, California. The delivery order was issued to de-obligate excess fiscal year 2025 funds under...
- This is a federal contract award to Veracyte, Inc., a for-profit medical diagnostic company, by the Veterans Integrated Service Network 23 (VISN 23), a division of the Department of Veterans Affairs (VA). The contract is an Indefinite Delivery, Indefinite Quantity (IDIQ) with a ceiling value of $112,200.00 for reference laboratory services. The contract is a firm fixed-price delivery order with an ultimate completion date of April 30, 2026. The contract is not set aside and was awarded on May 1,...
- This is a federal contract award by the Department of Veterans Affairs' Veterans Integrated Service Network (VISN) 23 to Veracyte, Inc., a medical diagnostic company specializing in advanced genomic testing services. The contract is an Indefinite Delivery/Indefinite Quantity (IDIQ) with a ceiling value of $72,800.00 for providing reference laboratory services. The contract is a firm fixed-price delivery order with an ultimate completion date of April 30, 2025. Veracyte will perform these testing...
- This is a $141,132.01 firm fixed price contract awarded by the Veterans Health Administration's Veterans Integrated Service Network 8 (VISN 8) to Veracyte, Inc., a for-profit provider of genomic testing services. The contract is for cancer screening tests, with no set-aside designation. Veracyte has also been awarded an Indefinite Delivery Indefinite Quantity (IDIQ) contract vehicle from VISN 23 to provide reference laboratory services, with a potential value of $600,000 through April 2028....
The Department of Veterans Affairs, Veterans Integrated Service Network 16 (VISN 16) awarded a definitive firm fixed-price contract to Veracyte, Inc. on December 14, 2020 for laboratory sample testing services with a ceiling value of $314,712.55 and an ultimate completion date of June 30, 2026. The work will be performed in North Little Rock, Arkansas. This award was not set aside for any socioeconomic designation and represents Veracyte's continued engagement with the VA to deliver specialized diagnostic testing services to veteran patient populations. Veracyte, Inc., a medical diagnostic company headquartered in South San Francisco, California, specializes in advanced genomic testing services, including proprietary molecular diagnostic tests for precision medicine applications. The company maintains an extensive federal contract portfolio serving multiple Veterans Integrated Service Networks, the Defense Health Agency, and the Indian Health Service through various indefinite delivery vehicles and blanket purchase agreements. This VISN 16 contract aligns with Veracyte's broader $890,640 indefinite delivery contract with VISN 16 for thyroid testing services through September 30, 2029, enabling VA facilities to access specialized genomic sequencing classifiers supporting precision cancer care initiatives across the VA healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00009 | Funding Only Action | ($34k) | 2/11/26 | |
| P00008 | Exercise an Option | $26.7k | 12/31/25 | |
| P00007 | Funding Only Action | ($20k) | 7/23/25 | |
| P00006 | Exercise an Option | $78.8k | 11/13/24 | |
| P00004 | Supplemental Agreement for work within scope | $6.9k | 12/26/23 |